Research

Research at the University of Washington have developed a smartphone app that may help prevent opioid overdose-related deaths.

The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) invites innovators to submit novel design solutions for its ASPIRE (A Specialized Platform for Innovative Research Exploration) Design Challenges.

The NIH Back Pain Consortium (BACPAC) Research Program, a component of the NIH HEAL (Helping to End Addiction Long-term) Initiative, has published four RFAs.

A new pain pathway has been discovered, which mediates the “soothing” response after injury – like blowing on a burn or cradling a hurt hand.

The NIH, as part of the Helping to End Addiction Long-Term (HEAL) initiative is planning to release a Funding Opportunity Announcement for clinical trials on comparative effectiveness research.

The National Center for Advancing Translational Sciences (NCATS) has released NOT-TR-19-007, a Notice of Intent to Publish a Funding Opportunity Announcement for Tissue Chips to Model Nociception, Addiction, and Overdose.

The 2019 CSDA competition is now open and accepting pre-proposals. The deadline to submit pre-proposals is November 28, 2018 at 3 pm ET.

Dr. Maixner, APS President, discusses the importance of researching and discovering new non-addictive chronic pain management therapies.

American Pain Society grant manager, Susan Vogel, shares the benefits of diversifying revenue sources.

Dr. Monroe, associate professor in The Ohio State University College of Nursing, has been awarded a five-year, $3.3 million R01 grant from The National Institutes of Health/National Institute on Aging (NIH/NIA).

A study by NIH focusing on High Impact Chronic Pain (HICP) was recently published in The Journal of Pain.

After more than two years since the National Institutes of Health (NIH) released its National Pain Strategy, and a year since announcing its Federal Pain Strategy the American Pain Society said today it is pleased and encouraged by significant progress that is occurring as a result toward achieving the goal of increased funding of pain research grants for both basic scientific and clinical studies..

Canadian researchers publish important findings about fibromyalgia patients participating in online acceptance commitment therapy in The Journal of Pain.

Illinois recently legalized medical cannabis as a substitute for prescription pain killers. APS Director-at-Large, Dr. Mark Wallace, adds his research and experience to the discussion.

The NIH Common Fund’s Acute to Chronic Pain Signatures program aims to understand the biological characteristics underlying the transition from acute to chronic pain and what makes some people susceptible and others resilient to the development of chronic pain.

Applications are due October 24, 2018.

Find out more about the NIH primer presented as a poster at the APS meeting to learn about the scientific rationale for including SABV in basic, preclinical, and clinical pain research.

APS Past President Dr. Roger Fillingim talks about the importance of identifying why pain exists for a patient rather than where it exists.

Eight senators submitted a letter to Attorney General Sessions Sessions regarding the status of 26 open applications to manufacture marijuana for research purposes.

A recent study found that patients who were educated on the neuroscience of pain and persisted in challenging physical therapy despite their chronic pain had better mental and physical health, and less disability than the standard treatment. The researchers conclude that staying active despite the pain can result in overall better health – including the pain itself.

APS Director-at-Large, Dr. Mark Wallace, appears in an article that reports on the positive impact of medical marijuana use among seniors.